Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Capital Expenditures (2018 - 2026)

Organogenesis Holdings has reported Capital Expenditures over the past 8 years, most recently at $4.7 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 38.41% year-over-year to $4.7 million; the TTM value through Dec 2025 reached $14.2 million, up 41.06%, while the annual FY2025 figure was $14.2 million, 41.06% up from the prior year.
  • Capital Expenditures for Q4 2025 was $4.7 million at Organogenesis Holdings, up from $2.2 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $28.4 million in Q4 2022 and troughed at -$22.2 million in Q4 2021.
  • A 5-year average of $4.3 million and a median of $3.3 million in 2023 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: surged 2080.39% in 2022 and later tumbled 4407.94% in 2023.
  • Year by year, Capital Expenditures stood at -$22.2 million in 2021, then soared by 227.46% to $28.4 million in 2022, then crashed by 88.28% to $3.3 million in 2023, then increased by 1.11% to $3.4 million in 2024, then surged by 38.41% to $4.7 million in 2025.
  • Business Quant data shows Capital Expenditures for ORGO at $4.7 million in Q4 2025, $2.2 million in Q3 2025, and $3.6 million in Q2 2025.